Nang Kuang Pharmaceutical Co., Ltd.

Total Valuation

Nang Kuang Pharmaceutical Co., Ltd. carries a market capitalization of 3.27B, placing it among publicly traded companies globally. Its enterprise value stands at 4.09B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Share Statistics

Nang Kuang Pharmaceutical Co., Ltd. currently has 100.99M shares outstanding.

Valuation Ratios

Nang Kuang Pharmaceutical Co., Ltd. trades at a trailing price-to-earnings ratio of 15.48. The price-to-sales ratio is 1.75, and the price-to-book ratio stands at 1.97.

Enterprise Valuation

On an enterprise value basis, Nang Kuang Pharmaceutical Co., Ltd. trades at an EV/EBITDA multiple of 13.84 and an EV/FCF ratio of 5.44. The EV/Sales ratio of 1.89 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 13.84 provides insight into valuation relative to core operating earnings.

Financial Position

Nang Kuang Pharmaceutical Co., Ltd. maintains a current ratio of 1.40, meaning it holds 1.4x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 26.35, indicating elevated leverage, while an interest coverage ratio of 34.41 demonstrates strong ability to service its debt obligations.

Financial Efficiency

Nang Kuang Pharmaceutical Co., Ltd. posts a return on equity of 13.16 and a return on invested capital of 7.94.

Taxes

Over the trailing twelve months, Nang Kuang Pharmaceutical Co., Ltd. has paid 47.20M in income taxes, reflecting an effective tax rate of 16.21.

Stock Price Statistics

Nang Kuang Pharmaceutical Co., Ltd.'s stock has declined approximately -8.73239% over the past 52 weeks. The 50-day moving average sits at 33.09, while the 200-day moving average is 36.21.

Income Statement

Over the trailing twelve months, Nang Kuang Pharmaceutical Co., Ltd. generated 2.16B in revenue and converted that into 244.41M in net income, yielding earnings per share of 2.40. EBITDA reached 295.66M, while operating income came in at 295.66M.

Balance Sheet

Nang Kuang Pharmaceutical Co., Ltd. holds 350.95M in cash and equivalents against 655.95M in total debt, resulting in a net debt position of 309.91M. Total book value stands at 1.92B, with working capital of 427.82M providing operational flexibility.

Cash Flow

Nang Kuang Pharmaceutical Co., Ltd. produced 464.08M in operating cash flow over the past twelve months. After subtracting -281.04M in capital expenditures, free cash flow totaled 183.03M - equivalent to 1.80 per share.

Margins

Nang Kuang Pharmaceutical Co., Ltd. operates with a gross margin of 35.56, reflecting its pricing power and cost economics. The operating margin of 13.67 and net profit margin of 11.30 provide insight into operational efficiency.

Dividends & Yields

Scores

Nang Kuang Pharmaceutical Co., Ltd. posts an Altman Z-Score of 2.99, near the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.